Skip to main content
. 2022 Aug 16;9:888604. doi: 10.3389/fcvm.2022.888604

Figure 3.

Figure 3

Change rates of low-density lipoprotein cholesterol (LDL-C), non-HDL-C (high-density lipoprotein cholesterol), HDL-C, TC (total cholesterol), TG (triglyceride), apoprotein B (Apo-B), and apoprotein A1 (Apo-A1) levels at 12 weeks from baseline in two treatment groups.